Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile
Iago Pinal-Fernandez

@driagopinal

Dr. Pinal-Fernandez is a Staff Clinician at the Muscle Disease Unit of NIAMS/NIH. His research is focused on understanding myositis and autoimmunity.

ID: 1451784072372523010

linkhttp://www.iagopinal.com calendar_today23-10-2021 05:34:54

70 Tweet

765 Followers

3,3K Following

Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trial. Rheumatology 2024. doi.org/10.1093/rheuma…

MitoMetLab (@mitometlab) 's Twitter Profile Photo

Check this recent work our lab has participated in collaboration with Iago Pinal-Fernandez NIH unraveling the pathophysiology of myositis through the internalization of autoantibodies into muscle fibers. pubmed.ncbi.nlm.nih.gov/38313303/

Check this recent work our lab has participated in collaboration with <a href="/DrIagoPinal/">Iago Pinal-Fernandez</a> <a href="/NIH/">NIH</a> unraveling the pathophysiology of myositis through the internalization of autoantibodies into muscle fibers. pubmed.ncbi.nlm.nih.gov/38313303/
Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Pathological autoantibody internalisation in myositis ard.bmj.com/content/early/… In myositis, autoantibodies are internalized into living cells, disrupting the function of their autoantigen. Annals of the Rheumatic Diseases 2024

Pathological autoantibody internalisation in myositis
ard.bmj.com/content/early/…

In myositis, autoantibodies are internalized into living cells, disrupting the function of their autoantigen.

Annals of the Rheumatic Diseases 2024
Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

In Myositis, Autoantibodies Get Inside Muscle Cells and Disrupt the Function of their Target Proteins niams.nih.gov/newsroom/spotl…

Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Quantification of Autoantibodies Using a Luminescent Profiling Method in Autoimmune Interstitial Lung Diseases. Frontiers in Immunology 2024. frontiersin.org/journals/immun…

Dr Ai Lyn Tan (@drailyntan) 's Twitter Profile Photo

Factors that contribute to #myositis-specific autoantibodies which can infiltrate #muscle cells ▶️Pre-existing diseases ▶️Microbial infections ▶️Medications ▶️Genetic predispositions ▶️Environmental exposures 👉🏽link.springer.com/article/10.100… by Iago Pinal-Fernandez et al

Factors that contribute to #myositis-specific autoantibodies which can infiltrate #muscle cells

▶️Pre-existing diseases
▶️Microbial infections
▶️Medications
▶️Genetic predispositions
▶️Environmental exposures

👉🏽link.springer.com/article/10.100…
by <a href="/DrIagoPinal/">Iago Pinal-Fernandez</a> et al
Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Immune Checkpoint Inhibitor Myopathy: The Double-Edged Sword of Cancer Immunotherapy. Neurology 2024. dx.doi.org/10.1212/WNL.00…

Teerin Liewluck, MD, FAAN, FANA (@tliewluck) 's Twitter Profile Photo

Emerging atypical manifestations of immune-mediate necrotizing #myopathy (#myositis): early recognition of these cases is very important. Time is muscle 💪 !!!! They can mimic #DistalMyopathy, #LGMD, #FSHD, and #OPMD. sciencedirect.com/science/articl…

Emerging atypical manifestations of immune-mediate necrotizing #myopathy (#myositis): early recognition of these cases is very important. Time is muscle 💪 !!!! They can mimic #DistalMyopathy, #LGMD, #FSHD, and #OPMD. 
sciencedirect.com/science/articl…
Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Unicorns, dragons, antisynthetase-negative antisynthetase syndrome, and other mythologic beasts. Annals of the Rheumatic Diseases 2025. doi.org/10.1016/j.ard.…

Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Mitochondrial damage is associated with an early immune response in inclusion body myositis. Brain 2025. doi.org/10.1093/brain/…

Iago Pinal-Fernandez (@driagopinal) 's Twitter Profile Photo

Exploring novel therapies for idiopathic inflammatory myopathies and examining future perspectives. Current Treatment Options in Rheumatology 2025. doi.org/10.1007/s40674…